BC Innovations | Jun 5, 2008
Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Indication Target/ marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Atherosclerosis; thrombosis L-selectin (CD62L); integrin b2 (CD18); platelets; resolvin E1 (RvE1) Ex vivo and mouse studies suggest that the...
BC Week In Review | Jan 29, 2001
Clinical News

Dona biomaterial/skin/wound, musculoskeletal data

University of Liege (Leige, Belgium) researchers published in The Lancet that in a 212-patient Belgian trial, patients taking 1.5 g of glucosamine daily for 3 years had joint-space loss of 0.06 mm while patients on...
Items per page:
1 - 2 of 2